Cigna Valuation
| C1IC34 Stock | BRL 416.67 7.49 1.83% |
At this time, the firm appears to be fairly valued. Cigna shows a prevailing Real Value of R$431.41 per share. The current price of the firm is R$416.67. Our model approximates the value of Cigna from analyzing the firm fundamentals such as Return On Equity of 0.14, current valuation of 675.25 B, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Cigna's price fluctuation is very steady at this time. Calculation of the real value of Cigna is based on 3 months time horizon. Increasing Cigna's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cigna is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cigna Stock. However, Cigna's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 416.67 | Real 431.41 | Hype 416.67 | Naive 415.34 |
The real value of Cigna Stock, also known as its intrinsic value, is the underlying worth of Cigna Company, which is reflected in its stock price. It is based on Cigna's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cigna's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cigna helps investors to forecast how Cigna stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cigna more accurately as focusing exclusively on Cigna's fundamentals will not take into account other important factors: Cigna Total Value Analysis
Cigna is currently forecasted to have takeover price of 675.25 B with market capitalization of 473.42 B, debt of 31.12 B, and cash on hands of 5.07 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cigna fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
675.25 B | 473.42 B | 31.12 B | 5.07 B |
Cigna Investor Information
The book value of the company was currently reported as 147.58. The company has Price/Earnings To Growth (PEG) ratio of 1.22. Cigna recorded earning per share (EPS) of 27.7. The entity last dividend was issued on the 7th of March 2023. Based on the key measurements obtained from Cigna's financial statements, Cigna is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Cigna Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cigna has an asset utilization ratio of 112.51 percent. This suggests that the Company is making R$1.13 for each dollar of assets. An increasing asset utilization means that Cigna is more efficient with each dollar of assets it utilizes for everyday operations.Cigna Profitability Analysis
The company reported the revenue of 174.27 B. Net Income was 5.37 B with profit before overhead, payroll, taxes, and interest of 23.16 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cigna's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cigna and how it compares across the competition.
About Cigna Valuation
The stock valuation mechanism determines Cigna's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cigna. We calculate exposure to Cigna's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cigna's related companies.Cigna Corporation provides insurance and related products and services in the United States. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut. CIGNA CORP operates under Healthcare Plans classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 72226 people.
8 Steps to conduct Cigna's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cigna's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cigna's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cigna's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cigna's revenue streams: Identify Cigna's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cigna's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cigna's growth potential: Evaluate Cigna's management, business model, and growth potential.
- Determine Cigna's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cigna's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Cigna Stock analysis
When running Cigna's price analysis, check to measure Cigna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cigna is operating at the current time. Most of Cigna's value examination focuses on studying past and present price action to predict the probability of Cigna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cigna's price. Additionally, you may evaluate how the addition of Cigna to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |